RadNet (RDNT) Investor update summary

Strategic rationale and integration

• Acquisition of Gleamer by RadNet, to be integrated into DeepHealth, aims to strengthen routine imaging and expand AI-powered health informatics globally.

• The combined entity will serve over 2,700 customer contracts worldwide, with a global footprint of 550 employees and 3,000+ healthcare provider locations.

• Gleamer brings a 90%+ annual recurring revenue growth rate and strong expertise in X-ray and European markets.

• Integration will focus on merging product portfolios, leveraging complementary regulatory clearances, and ensuring no disruption to existing customers.

• The partnership accelerates the roadmap toward automated diagnostics, with a focus on workflow optimization and AI-driven reporting.

Financial and operational outlook

• DeepHealth reported $93 million in revenue for 2025, with $75 million ARR and 35%+ recurring revenue growth.

• Gleamer is projected to contribute $30 million ARR by 2026, maintaining its high growth trajectory.

• Combined 2026 guidance is $135–$145 million in revenue and $120–$140 million ARR, implying 80–90% ARR growth.

• Identified cost synergies include $2 million in direct savings and operational efficiencies from team integration.

• Commercial synergies expected through cross-selling, upselling, and expansion in both U.S. and EMEA markets.

Product and technology expansion

• The combined portfolio now covers over 75 clinical indications across multiple specialties, making it the largest in the industry.

• Enhanced R&D capabilities with over 70 employees in research and development and 40 in commercial roles.

• Expansion into new modalities such as musculoskeletal MR, holistic lung CT, and automated mammography reporting.

• Focus on automating workflows, triage, and reporting to address radiologist shortages and improve patient outcomes.

• Launch of the combined portfolio at ECR, showcasing unified solutions to customers as one company.